Medical device labeling is the full set of information that accompanies a device, including the label on the unit itself, packaging inserts, instructions for use (IFU), and any onscreen or software-driven labeling. It identifies the device, states its intended use, and provides the warnings, symbols, and traceability data, such as UDI, needed for safe handling by clinicians and patients.
What is Medical Device Labeling?
Labeling covers every piece of information a manufacturer attaches to or ships with a device: the primary label on the unit, secondary packaging labels, IFU booklets, symbols per ISO 15223-1, and any labeling built into software interfaces for connected or SaMD products. Regulators treat labeling as part of the device itself, not an afterthought added after design freeze.
Labeling development starts early in design controls and continues through design transfer, manufacturing, and post-market change control. Draft label content typically emerges alongside design inputs and outputs, gets verified against design specifications, and is validated with representative users before a device reaches market. Any change to intended use, warnings, or claims triggers a labeling update, which is why sustaining engineering teams track it as a living document instead of a one-time deliverable.
Why Medical Device Labeling Matters in Development
Mislabeling is one of the most common reasons for a device recall. A missing contraindication, an incorrect symbol, or an IFU that does not match the approved indications can lead directly to patient harm and a Class I or Class II recall under FDA rules.
Labeling errors also carry direct regulatory and commercial costs. FDA and EU notified bodies review labeling as part of 510(k), PMA, and MDR technical file submissions, and a labeling deficiency can stall clearance for months. Once a device is on the market, labeling sits inside the technical documentation that auditors pull first, so inconsistent revision history or an untranslated IFU is a common audit finding. Getting labeling right the first time protects both patients and launch timelines.
How Medical Device Labeling Works
Labeling content is governed by region-specific rules rather than one global standard, though the core elements overlap closely across markets. A compliant device label generally includes:
- Device name, model, and intended use statement
- Manufacturer name, address, and legal manufacturer designation
- Lot or serial number and manufacturing date
- UDI (Unique Device Identifier) carrier, required under FDA 21 CFR Part 801 and EU MDR 2017/745
- Sterility status and expiration date, where applicable
- Warnings, contraindications, and storage conditions
- Symbols per ISO 15223-1, with a symbol glossary if space is limited
- Language localized to the country of sale.
In the US, labeling requirements fall under FDA 21 CFR Part 801, with device-specific rules layered on top for certain product types. In the EU, labeling content requirements sit in EU MDR 2017/745 Annex I, Chapter III, and in IVDR 2017/746 for diagnostics. Instructions for use are treated as part of the label and are subject to the same design control and translation requirements as the physical label. Packaging that carries labeling, such as a sterile barrier system, is validated under ISO 11607 to confirm the label survives sterilization, shipping, and storage without becoming illegible.
Common Challenges and Best Practices
Teams most often get tripped up by three things: late-stage label changes that skip a design control review, translation errors introduced during localization, and UDI data that does not match what was submitted to a database such as the FDA’s GUDID or the EU’s EUDAMED.
Good practice treats labeling as a controlled document from day one. Label content should trace back to specific design inputs and risk file entries, not get drafted separately by a marketing or packaging team late in development. Symbol use should follow ISO 15223-1 rather than inventing custom icons, since regulators and users both expect the standard set. Translation and back-translation should run through a qualified process with version control, and any wording change, however small, should pass through the same change control gate as a hardware revision. Building a labeling checklist into design transfer catches most of these issues before they reach the shop floor.
How SJML Helps with Medical Device Labeling
SJML supports labeling as part of combined manufacturing and QARA services rather than as a separate line item. On the manufacturing side, this includes sterile and non-sterile packaging and labeling with process validation, so label content is verified against approved artwork before a device ships. On the regulatory side, SJML’s compliance-as-a-service team supports labeling and packaging within regulatory sustenance work, alongside DHF maintenance, UDI-related activities, and EUDAMED-related documentation. Because design, manufacturing, and QARA sit under one roof, a labeling change can be traced back to its design input and forward into production without gaps between teams.
Frequently Asked Questions
The label is the information printed directly on the device or its immediate packaging, such as the lot number and warnings. The instructions for use (IFU) are a separate document, often a booklet or electronic file, that explains how to use the device safely. Regulators treat both as part of “labeling” under FDA and EU MDR rules, so both go through the same design control and translation process.
Yes. Onscreen text, warnings, and instructions built into a device’s user interface or a standalone software as a medical device product count as labeling if they convey required information such as intended use or warnings. This “eLabeling” must meet the same content rules as printed labels and is reviewed in the same way during a regulatory submission.
UDI, or Unique Device Identifier, is a code, usually printed as a barcode or Data Matrix, that identifies a specific device model and production batch. FDA and EU MDR both require UDI on labeling for most device classes. It ties the physical label to database records in systems such as GUDID or EUDAMED, which support recalls, adverse event tracking, and supply chain traceability.
A mismatch between marketed labeling and what was cleared or approved is a common cause of warning letters, import holds, or recalls. Regulators expect labeling content, including claims and indications, to match the approved submission exactly. Any change to intended use or key warnings after clearance generally requires a new submission or a formal change assessment before the updated label can ship.
Related terms
- Instructions for Use (IFU)
- Unique Device Identification (UDI)
- Design Verification
- EU MDR 2017/745
- Packaging Validation (ISO 11607)
